HBB rs752856716: Understanding This Rare Genetic Variant
The rs752856716 variant is a rare single nucleotide change located within the HBB gene, which encodes the beta-globin subunit of hemoglobin. It is primarily recognized as an ancestry-informative marker used in population genetics and studies related to hemoglobinopathy screening.
What each genotype means
Typical beta-globin profile
This genotype represents the most common sequence found in the HBB gene for this specific variant location. It is considered the baseline state, and there is no evidence suggesting this specific configuration contributes to hemoglobin-related health conditions.
This is the most common genotype globally, found in the vast majority of individuals across all ancestral populations.
Rare variant carrier
You carry one copy of the rare G allele at this position in the HBB gene. Because this variant is very rare and evidence regarding its clinical significance is limited, it is currently classified as a marker of population ancestry rather than a known cause of disease.
This genotype is very rare globally, with a minor allele frequency typically reported as less than 0.001 in non-African populations.
Rare variant homozygous
You carry two copies of the rare G allele at this position in the HBB gene. Given the limited research on this specific variant, its functional impact on hemoglobin production remains uncertain, and it is not currently linked to clinical hemoglobinopathies.
This genotype is extremely rare and is observed only in a very small fraction of the global population.
What is the rs752856716 Variant?
The rs752856716 variant is a specific change in the DNA sequence of the HBB gene. In genomics, an rsID (reference SNP cluster ID) like rs752856716 acts as a unique identifier for a specific location in the human genome where a single nucleotide polymorphism (SNP) has been observed. This particular variant is categorized as a structural, ancestry-informative marker. This means that while it may not necessarily cause a disease on its own, its presence or absence can help researchers understand the ancestral background of a population. Because it is located within the beta-globin locus, it is often studied in the context of how genetic diversity is distributed across different global populations.
The Role of the HBB Gene
The HBB gene provides the essential instructions for producing a protein called beta-globin. Beta-globin is a critical component of hemoglobin, the complex protein found in red blood cells that is responsible for transporting oxygen from the lungs to the rest of the body. Hemoglobin is composed of multiple subunits, and the proper assembly of these subunits is vital for maintaining healthy blood function. Variations in the HBB gene are well-known in medical literature because they can lead to various hemoglobinopathies, such as sickle cell disease or beta-thalassemia, when the protein structure is significantly altered. Understanding the HBB gene is fundamental to hematology and the study of inherited blood disorders.
Research and Evidence Strength
Current evidence regarding the clinical impact of rs752856716 is considered limited. While the HBB gene itself is highly significant and well-studied due to its role in severe blood conditions, not every variant within or near this gene is pathogenic. Research into rs752856716 primarily focuses on its utility in population stratification—the process of identifying genetic differences between groups of people. Because the evidence for this specific variant is limited, it is not typically used as a standalone diagnostic tool for clinical conditions. Researchers continue to monitor such variants to better understand the full spectrum of human genetic diversity and to refine screening protocols for hemoglobin-related traits.
Interpreting Your Information
If you have received information about this variant through a genetic report, it is important to view it in the proper context. Because rs752856716 is a rare variant with limited evidence of clinical impact, it is generally not used to predict health outcomes or diagnose medical conditions. Genetic data can be complex, and population-level associations do not always translate to individual health risks. If you have concerns about your hemoglobin levels, blood health, or family history of blood disorders, the most appropriate step is to consult with a qualified healthcare provider or a genetic counselor. They can help interpret your results in the context of your overall health and provide guidance on whether further clinical testing is necessary.
How common is this variant?
The rs752856716 variant is very rare globally, with a minor allele frequency typically reported as less than 0.001 in non-African populations.
Frequently asked questions
Is rs752856716 associated with sickle cell disease?
No, rs752856716 is not a known cause of sickle cell disease. While it is located in the HBB gene, it is primarily categorized as an ancestry-informative marker rather than a pathogenic mutation linked to specific hemoglobinopathies.
Should I be worried if I have this variant?
There is no reason for concern based on this variant alone. It is a rare genetic marker with limited evidence of clinical impact, and it is not used for medical diagnosis.
How can I find out if I have this variant?
This variant is typically identified through specialized genetic testing or large-scale genomic sequencing studies. It is not a standard marker included in routine clinical blood panels.
What does 'ancestry-informative' mean?
An ancestry-informative marker is a genetic variant that appears at different frequencies in different human populations. Researchers use these markers to help estimate the ancestral background of individuals or groups.
Sources & further reading
Educational information only, last refreshed 10/14/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs752856716?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in HBB
This variant is a pathogenic mutation in the HBB gene associated with beta-thalassemia.
This variant is a pathogenic mutation in the HBB gene associated with hemoglobinopathies such as sickle cell disease.
This variant (c.20A>T, p.Glu7Val) causes the substitution of valine for glutamic acid in the beta-globin chain, leading to sickle cell trait or disease depending on zygosity.
Pathogenic variant (p.Glu6Val, HbS-Antilles) in HBB associated with sickle cell disease-like pathology.
Pathogenic nonsense mutation (c.118C>T / p.Gln40Ter / codon 39 nonsense) causing beta-zero thalassemia and classic carrier status (beta-thalassemia minor).
This variant, known as Hb C-Harlem, involves a double mutation in the HBB gene that can lead to sickle-beta-thalassemia-like phenotypes.